New cancer drug ADCX-020 enters first human tests
Disease control
Recruiting now
This early-phase study tests a new cancer drug called ADCX-020 in 290 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody drug conjugate designed to target and kill cancer cells. The study first finds the safest dose, then tes…
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated May 26, 2026 11:34 UTC